These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 33947209)

  • 41. Safety and Efficacy of Intravenous Low-Dose Alteplase in Relative Contraindication Patients with Acute Ischemic Stroke.
    Ohta T; Okada K; Fukuda M; Masahira N; Matsuoka T; Tsuno T; Takemura M
    J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):1844-1851. PubMed ID: 29555402
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Validation of the simplified modified Rankin scale for stroke trials: Experience from the ENCHANTED alteplase-dose arm.
    Chen X; Li J; Anderson CS; Lindley RI; Hackett ML; Robinson T; Lavados PM; Wang X; Arima H; Chalmers J; Delcourt C;
    Int J Stroke; 2021 Feb; 16(2):222-228. PubMed ID: 31969072
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The efficacy and safety of intravenous thrombolysis with alteplase in the treatment of ischaemic stroke in a rural hospital.
    Sobolewski P; Sledzińska-Dźwigał M; Szczuchniak W; Hatalska-Żerebiec R; Grzesik M; Sobota A
    Neurol Neurochir Pol; 2013; 47(4):310-8. PubMed ID: 23986420
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative effects of low-dose versus standard-dose alteplase in ischemic patients with prior stroke and/or diabetes mellitus: The ENCHANTED trial.
    Chen G; Wang X; Robinson TG; Pikkemaat M; Lindley RI; Zhou S; Ping L; Liu W; Liu L; Chalmers J; Anderson CS;
    J Neurol Sci; 2018 Apr; 387():1-5. PubMed ID: 29571842
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical Course of Acute Ischemic Stroke Due to Medium Vessel Occlusion With and Without Intravenous Alteplase Treatment.
    Ospel JM; Menon BK; Demchuk AM; Almekhlafi MA; Kashani N; Mayank A; Fainardi E; Rubiera M; Khaw A; Shankar JJ; Dowlatshahi D; Puig J; Sohn SI; Ahn SH; Poppe A; Calleja A; Hill MD; Goyal M
    Stroke; 2020 Nov; 51(11):3232-3240. PubMed ID: 33070714
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characteristics, management and response to alteplase in China versus non-China participants of the ENCHANTED trial.
    Song L; Wang X; Robinson T; Lindley RI; Arima H; Lavados PM; Chen X; Chalmers J; Anderson CS
    Stroke Vasc Neurol; 2017 Jun; 2(2):53-58. PubMed ID: 28959492
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of Alteplase on Ischemic Stroke Mortality Is Dependent on Stroke Severity.
    de Havenon A; Abbasi M; Yaghi S; Delic A; Bangad A; Johnston K; Tirschwell D; Sheth KN
    Ann Neurol; 2023 Jun; 93(6):1106-1116. PubMed ID: 36852919
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Off-label thrombolysis versus full adherence to the current European Alteplase license: impact on early clinical outcomes after acute ischemic stroke.
    Cappellari M; Moretto G; Micheletti N; Donato F; Tomelleri G; Gulli G; Carletti M; Squintani GM; Zanoni T; Ottaviani S; Romito S; Tommasi G; Musso AM; Deotto L; Gambina G; Zimatore DS; Bovi P
    J Thromb Thrombolysis; 2014 May; 37(4):549-56. PubMed ID: 23943338
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictors of Good Outcomes in Stroke Thrombolysis Guided by Tissue-Window.
    Zhang X; Wang D; Wang H; Cai X; Shi H; Fang Q
    Neurologist; 2020 Dec; 26(1):1-5. PubMed ID: 33394903
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serious Adverse Events and Their Impact on Functional Outcome in Acute Ischemic Stroke in the WAKE-UP Trial.
    Lettow I; Jensen M; Schlemm E; Boutitie F; Quandt F; Cheng B; Ebinger M; Endres M; Fiebach JB; Thijs V; Lemmens R; Muir KW; Nighoghossian N; Pedraza S; Simonsen CZ; Gerloff C; Thomalla G;
    Stroke; 2021 Dec; 52(12):3768-3776. PubMed ID: 34433305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Routine Use of Tenecteplase for Thrombolysis in Acute Ischemic Stroke.
    Zhong CS; Beharry J; Salazar D; Smith K; Withington S; Campbell BCV; Wilson D; Le Heron C; Mason D; Duncan R; Reimers J; Mein-Smith F; Diprose WK; Barber PA; Ranta A; Fink JN; Wu TY
    Stroke; 2021 Mar; 52(3):1087-1090. PubMed ID: 33588597
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of ischemic stroke onset time with presenting severity, acute progression, and long-term outcome: A cohort study.
    Ryu WS; Hong KS; Jeong SW; Park JE; Kim BJ; Kim JT; Lee KB; Park TH; Park SS; Park JM; Kang K; Cho YJ; Park HK; Lee BC; Yu KH; Oh MS; Lee SJ; Kim JG; Cha JK; Kim DH; Lee J; Han MK; Park MS; Choi KH; Lee J; Saver JL; Lo EH; Bae HJ; Kim DE
    PLoS Med; 2022 Feb; 19(2):e1003910. PubMed ID: 35120123
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endovascular Thrombectomy for Mild Strokes: How Low Should We Go?
    Sarraj A; Hassan A; Savitz SI; Grotta JC; Cai C; Parsha KN; Farrell CM; Imam B; Sitton CW; Reddy ST; Kamal H; Goyal N; Elijovich L; Reishus K; Krishnan R; Sangha N; Wu A; Costa R; Malik R; Mir O; Hasan R; Snodgrass LM; Requena M; Graybeal D; Abraham M; Chen M; McCullough LD; Ribo M
    Stroke; 2018 Oct; 49(10):2398-2405. PubMed ID: 30355094
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thrombolysis with alteplase for acute ischemic stroke patients with atrial fibrillation.
    Zhang JB; Ding ZY; Yang Y; Sun W; Hai F; Sui XN; Li XY; Wang HZ; Wang XT; Zheng JL
    Neurol Res; 2010 May; 32(4):353-8. PubMed ID: 20483000
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.
    Albers GW; Bates VE; Clark WM; Bell R; Verro P; Hamilton SA
    JAMA; 2000 Mar; 283(9):1145-50. PubMed ID: 10703776
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thrombolysis With Alteplase at 0.6 mg/kg for Stroke With Unknown Time of Onset: A Randomized Controlled Trial.
    Koga M; Yamamoto H; Inoue M; Asakura K; Aoki J; Hamasaki T; Kanzawa T; Kondo R; Ohtaki M; Itabashi R; Kamiyama K; Iwama T; Nakase T; Yakushiji Y; Igarashi S; Nagakane Y; Takizawa S; Okada Y; Doijiri R; Tsujino A; Ito Y; Ohnishi H; Inoue T; Takagi Y; Hasegawa Y; Shiokawa Y; Sakai N; Osaki M; Uesaka Y; Yoshimura S; Urabe T; Ueda T; Ihara M; Kitazono T; Sasaki M; Oita A; Yoshimura S; Fukuda-Doi M; Miwa K; Kimura K; Minematsu K; Toyoda K;
    Stroke; 2020 May; 51(5):1530-1538. PubMed ID: 32248771
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines-Stroke registry.
    Romano JG; Smith EE; Liang L; Gardener H; Camp S; Shuey L; Cook A; Campo-Bustillo I; Khatri P; Bhatt DL; Fonarow GC; Sacco RL; Schwamm LH
    JAMA Neurol; 2015 Apr; 72(4):423-31. PubMed ID: 25642650
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of Endovascular Treatment Alone vs Intravenous Alteplase Plus Endovascular Treatment on Functional Independence in Patients With Acute Ischemic Stroke: The DEVT Randomized Clinical Trial.
    Zi W; Qiu Z; Li F; Sang H; Wu D; Luo W; Liu S; Yuan J; Song J; Shi Z; Huang W; Zhang M; Liu W; Guo Z; Qiu T; Shi Q; Zhou P; Wang L; Fu X; Liu S; Yang S; Zhang S; Zhou Z; Huang X; Wang Y; Luo J; Bai Y; Zhang M; Wu Y; Zeng G; Wan Y; Wen C; Wen H; Ling W; Chen Z; Peng M; Ai Z; Guo F; Li H; Guo J; Guan H; Wang Z; Liu Y; Pu J; Wang Z; Liu H; Chen L; Huang J; Yang G; Gong Z; Shuai J; Nogueira RG; Yang Q;
    JAMA; 2021 Jan; 325(3):234-243. PubMed ID: 33464335
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictors of the unfavorable outcomes in acute ischemic stroke patients treated with alteplase, a multi-center randomized trial.
    Zeinhom MG; Khalil MFE; Kamel IFM; Kohail AM; Ahmed SR; Elbassiouny A; Shuaib A; Al-Nozha OM
    Sci Rep; 2024 Mar; 14(1):5960. PubMed ID: 38472241
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of alteplase within 6 hours of acute ischemic stroke on all-cause mortality (third International Stroke Trial).
    Whiteley WN; Thompson D; Murray G; Cohen G; Lindley RI; Wardlaw J; Sandercock P;
    Stroke; 2014 Dec; 45(12):3612-7. PubMed ID: 25370587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.